Gene therapy injected in one eye can travel to the other eye
By Clare Wilson,
New Scientist
| 12. 09. 2020
A gene therapy for a rare form of blindness seems to work well – but the genes injected into one eye have been found to travel to the untreated eye. The discovery has implications for safety, as well as for how the therapy’s effectiveness is measured, because such trials usually compare the treated eye’s vision with that of the untreated eye.
The experimental therapy is for a condition called Leber’s hereditary optic neuropathy, which usually affects young men and leads to progressive sight loss. It is caused by a mutation in one of the genes inside mitochondria, the energy-producing structures inside cells. This kills off cells of the retina, the patch of tissue at the back of the eye that turns light into electrical signals.
The gene therapy involves injecting a harmless virus containing the gene into the eye, where it is taken up by retinal cells. These start making the protein encoded by this gene, which passes into their mitochondria and helps preserve their remaining retina.
Eye disorders are a popular target for gene therapies, because they can...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...